Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Final Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Alexey Danilov, MD PhD, Habte A Yimer, MD, Michael Boxer, MD, John M Burke, MD, Sunil Babu, MD, Jia Li, PhD, Yong Mun, PhD, Peter C Trask, PhD MPH, Anthony S Masaquel, PhD MPH, Jeff P. Sharman, MD

Blood (2019) 134 (Supplement_1): 3491.

https://doi.org/10.1182/blood-2019-123630

Published: 2019

Journal Articles

Progression By Lymphocytosis Correlates with Favourable Long-Term Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL)

Alexandra Bazeos, Craig Gower, Francine Swann, Peter C Trask, Mark Dixon, BSc MSC, Noelle Crompton, Nelson Kinnersley, Othman Al-Sawaf, MD, Valentin Goede, MD, Günter Fingerle-Rowson, Kathryn Humphrey, PhD

Blood (2016) 128 (22): 4352.

https://doi.org/10.1182/blood.V128.22.4352.4352

Published: 2016

Journal Articles

The Prognostic Value for Survival of Patient-Reported Outcomes in Hematological Malignancies: A Systematic Review

Avrita Campinha-Bacote, BS MPH, Peter C Trask, Fabio Efficace, PhD

Blood (2016) 128 (22): 4793.

https://doi.org/10.1182/blood.V128.22.4793.4793

Published: 2016

Journal Articles

Evaluation of Fatigue in Previously Untreated CLL Patients with Comorbidities Treated with Obinutuzumab (GA101) + Chlorambucil (GClb) or Rituximab + Chlorambucil (RClb)

Valentin Goede, MD, Peter C Trask, Katharina Ziesel, Marianne Uguen, MSc, Alexandra Bazeos, Kirsten Fischer, MD, Michael Hallek, MD

Blood (2016) 128 (22): 2401.

https://doi.org/10.1182/blood.V128.22.2401.2401

Published: 2016

Journal Articles

Primary Results of the Health-Related Quality of Life Assessment from the Phase III Gadolin Study of Obinutuzumab Plus Bendamustine Compared with Bendamustine Alone in Patients with Rituximab-Refractory, Indolent Non-Hodgkin Lymphoma

Bruce D. Cheson, MD, Peter C Trask, PhD MPH, John Gribben, MDDSc, Natalie Dimier, Eva Kimby, MD PhD, Pieternella J Lugtenburg, MD PhD, Catherine Thieblemont, Elisabeth Wassner Fritsch, MD, Laurie H Sehn, MD MPH

Blood (2015) 126 (23): 1532.

https://doi.org/10.1182/blood.V126.23.1532.1532

Published: 2015

Journal Articles

Meta-Analytic Summary of the Burden of Pain and Fatigue in Multiple Myeloma

Peter C. Trask, PhD MPH, Mark Atkinson, PhD, Bhumi Trivedi, MBA, Andrew Palsgrove, BA, William Benton Jones, PhDMBA, Colleen McHorney, PhD

Blood (2014) 124 (21): 5967.

https://doi.org/10.1182/blood.V124.21.5967.5967

Published: 2014

Journal Articles

Symptoms of Multiple Myeloma: Results of Hybrid Concept Elicitation/Cognitive Debriefing Interviews

Peter C. Trask, PhD MPH, Bhumi Trivedi, MBA, Andrew Palsgrove, BA, William Benton Jones, PhDMBA, Colleen McHorney, PhD

Blood (2014) 124 (21): 5973.

https://doi.org/10.1182/blood.V124.21.5973.5973

Published: 2014

Journal Articles

Qualitative Assessment Of Symptoms and Functional Impact In Relapsed/Refractory Multiple Myeloma Patients and Comparison To The EORTC QLQ-C30 and My-20, FACT-MM, and MDASI-MM

Peter C Trask, PhD, MPH, Fiona Taylor, MBiochem, Alan Shields, PhD, Meghan Gallagher, MSc, Jyotsna Mehta, MSc, Catherine Foley, MPH, Funke Olude, MPH, Roger Lamoureux, Ramon Iovin, PhD, Karl Hsu, MD

Blood (2013) 122 (21): 2989.

https://doi.org/10.1182/blood.V122.21.2989.2989

Published: 2013

Journal Articles

Efficacy and Safety Of Treatments For Relapsed Or Refractory Mantle Cell Lymphoma (MCL): Results Of a Systematic Literature Review

Annete Njue, PhD, Peter C Trask, PhD, MPH, Ann Colosia, PhD, Robert Olivares, MD, MSc, Shahnaz Khan, MPH, Adeline Abbe, MSc, Rachel Lee Police, MPH, Jianmin Wang, PhD, MD, Elizabeth Sherrill, MS, James A. Kaye, MD, DrPH, Farrukh T Awan, MD

Blood (2013) 122 (21): 5099.

https://doi.org/10.1182/blood.V122.21.5099.5099

Published: 2013

Journal Articles

Efficacy and Safety Of Treatments For Relapsed Or Refractory DLBCL: Results Of a Systematic Literature Review

Ann Colosia, PhD, Peter C Trask, PhD, MPH, Robert Olivares, MD, MSc, Shahnaz Khan, MPH, Adeline Abbe, MSc, Rachel Lee Police, MPH, Annete Njue, PhD, Jianmin Wang, PhD, MD, Elizabeth Sherrill, MS, Rodrigo Ruiz-Soto, MD, MSc, James A. Kaye, MD, DrPH, Farrukh T Awan, MD

Blood (2013) 122 (21): 5104.

https://doi.org/10.1182/blood.V122.21.5104.5104

Published: 2013

Journal Articles

Treatments For Relapsed Or Refractory Follicular Lymphoma (RRFL): Results Of a Systematic Literature Review (SLR) and Meta-Analysis

Rachel Lee Police, MPH, Peter C Trask, PhD, MPH, Ann Colosia, PhD, Robert Olivares, MD, MSc, Shahnaz Khan, MPH, Adeline Abbe, MSc, Annete Njue, PhD, Jianmin Wang, PhD, MD, Sherrill Elizabeth, MS, James A. Kaye, MD, DrPH, Rodrigo Ruiz-Soto, MD, MSc, Mehdi Hamadani, MD

Blood (2013) 122 (21): 5106.

https://doi.org/10.1182/blood.V122.21.5106.5106

Published: 2013

Journal Articles

Difficulties with Measuring the Patient's Perspective in Non Hodgkin's Lymphoma - a Review of Patient Reported Outcome Measures

Jyotsna Mehta, Florence Joulain, Peter C Trask, Bonnie Teschendorf

Blood (2012) 120 (21): 4703.

https://doi.org/10.1182/blood.V120.21.4703.4703

Published: 2012

Journal Articles

Need for Patient Reported Outcomes (PRO) in Adult Acute Lymphoblastic Leukemia (ALL)

Jyotsna Mehta, Florence Joulain, Kelly Hageman, Peter C Trask

Blood (2012) 120 (21): 4704.

https://doi.org/10.1182/blood.V120.21.4704.4704

Published: 2012

Journal Articles

Epidemiology Projection Trends for Hodgkin Lymphoma Patients in the U.S. and Europe

Jyotsna Mehta, Adeline Abbe, Peter C Trask, Frank Neumann, Alaa Hamed

Blood (2012) 120 (21): 4782.

https://doi.org/10.1182/blood.V120.21.4782.4782

Published: 2012

Journal Articles

Epidemiology Projection Trends for Non-Hodgkin Lymphoma (NHL) and Its Subtypes in the United States (US) and Europe (EU)

Peter C Trask, Jyotsna Mehta, Adeline Abbe, Rodrigo RuizSoto

Blood (2012) 120 (21): 5074.

https://doi.org/10.1182/blood.V120.21.5074.5074

Published: 2012

Journal Articles

Health Care Resource Utilization and Cost in Patients with Chronic Myeloid Leukemia in a Privately Insured Patient Population in the United States,

Shrividya Iyer, PhD, Peter C Trask, PhD, MPH, Gordon Siu, MS, Jack Mardekian, PhD

Blood (2011) 118 (21): 4220.

https://doi.org/10.1182/blood.V118.21.4220.4220

Published: 2011

Journal Articles

Treatment Response Patterns and Related Prognostic Indicators in Chronic Myeloid Leukemia (CML) Patients: A Multi-Country Medical Record Review Study

Peter C Trask, PhD, MPH, Debanjali Mitra, MA, MBA, Shrividya Iyer, PhD, Sean D Candrilli, PhD, James A. Kaye, MD, DrPH

Blood (2011) 118 (21): 3131.

https://doi.org/10.1182/blood.V118.21.3131.3131

Published: 2011

NARROW

Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Final Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Progression By Lymphocytosis Correlates with Favourable Long-Term Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL)

The Prognostic Value for Survival of Patient-Reported Outcomes in Hematological Malignancies: A Systematic Review

Evaluation of Fatigue in Previously Untreated CLL Patients with Comorbidities Treated with Obinutuzumab (GA101) + Chlorambucil (GClb) or Rituximab + Chlorambucil (RClb)

Primary Results of the Health-Related Quality of Life Assessment from the Phase III Gadolin Study of Obinutuzumab Plus Bendamustine Compared with Bendamustine Alone in Patients with Rituximab-Refractory, Indolent Non-Hodgkin Lymphoma

Meta-Analytic Summary of the Burden of Pain and Fatigue in Multiple Myeloma

Symptoms of Multiple Myeloma: Results of Hybrid Concept Elicitation/Cognitive Debriefing Interviews

Qualitative Assessment Of Symptoms and Functional Impact In Relapsed/Refractory Multiple Myeloma Patients and Comparison To The EORTC QLQ-C30 and My-20, FACT-MM, and MDASI-MM

Efficacy and Safety Of Treatments For Relapsed Or Refractory Mantle Cell Lymphoma (MCL): Results Of a Systematic Literature Review

Efficacy and Safety Of Treatments For Relapsed Or Refractory DLBCL: Results Of a Systematic Literature Review

Treatments For Relapsed Or Refractory Follicular Lymphoma (RRFL): Results Of a Systematic Literature Review (SLR) and Meta-Analysis

Difficulties with Measuring the Patient's Perspective in Non Hodgkin's Lymphoma - a Review of Patient Reported Outcome Measures

Need for Patient Reported Outcomes (PRO) in Adult Acute Lymphoblastic Leukemia (ALL)

Epidemiology Projection Trends for Hodgkin Lymphoma Patients in the U.S. and Europe

Epidemiology Projection Trends for Non-Hodgkin Lymphoma (NHL) and Its Subtypes in the United States (US) and Europe (EU)

Health Care Resource Utilization and Cost in Patients with Chronic Myeloid Leukemia in a Privately Insured Patient Population in the United States,

Treatment Response Patterns and Related Prognostic Indicators in Chronic Myeloid Leukemia (CML) Patients: A Multi-Country Medical Record Review Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only